By Kal Kurdi, September 7th, 2014 | No Comments
BioCryst Pharmaceuticals say they have developed a new drug which safely inhibits flu symptoms if administered to patients within the first 48 hours from the onset of the flu. Peramivir, BioCryst’s new neuraminidase inhibitor (NAI) vaccine is also known as RAPIVAB. A new study that was recently rele...
Also read: Trump revels in the secretary of state show